Project Grant 15PJDP21GG02831DGCT

This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund a $953,802 study by The Ohio State University to develop and evaluate a supervision coaching strategy called Cross-system Technical Assistance for Retaining Staff (COSTARS). COSTARS aims to improve workforce stability and implementation of the Sobriety Treatment and Recovery Teams (START) intervention among 53 Ohio child welfare agencies. The...

This Cooperative Agreement award from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, is for a project titled "Strengthening Buprenorphine Treatment for Individuals in Carceral Settings (STAND): A Hybrid Implementation-Effectiveness Trial of Long-Acting Injectable versus Sublingual Buprenorphine." The project aims to conduct a large randomized controlled trial comparing the effectiveness of long-acting injectable buprenorphine versus sublingual...

The National Institute on Drug Abuse (NIDA) has awarded a $731,275 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Massachusetts Medical School (UMMS) to support the "Supporting Treatment Access and Recovery in Re-entry (STAR-R)" study. The 5-year study will evaluate the effectiveness of the "Maintaining Independence and Sobriety through Systems Integration, Outreach, and Networking-Criminal Justice Version (MISSION-CJ)"...

This federal Formula Grant award from the U.S. Department of Justice's Bureau of Justice Assistance (CFDA 16.593 - Residential Substance Abuse Treatment for State Prisoners Program) provides $252,357 to the Massachusetts Department of Public Safety Executive Office to support substance use disorder (SUD) treatment and rehabilitation services within state and local correctional facilities. The key objectives are to reduce substance abuse, decrease recidivism, and facilitate successful community...

This Project Grant award from the National Institute on Drug Abuse (NIDA), part of the Drug Use and Addiction Research Programs (CFDA 93.279), provides $456,600.00 to Wayne State University to establish sustainable infrastructure for multi-tiered substance use disorder (SUD) prevention programs in high schools. The project, titled "Reducing Addiction through Prevention Infrastructure Development (RAPID)", focuses on adapting and refining a multi-phase implementation...

The New York State Division of Criminal Justice Services (DCJS) was awarded a $812,171 Formula Grant under the U.S. Department of Justice's Bureau of Justice Assistance Residential Substance Abuse Treatment (RSAT) for State Prisoners Program (CFDA 16.593). The grant will fund residential substance use disorder (SUD) treatment programs at three DOCCS (New York State Department of Corrections and Community Supervision) correctional facilities - Marcy, Wallkill, and Collins - over a four-year...

The County of Stanislaus, California is receiving $1,599,999 in continuation funding from the Bureau of Justice Assistance (BJA) Fiscal Year 2023 Comprehensive Opioid, Stimulant, and Substance Use Site-Based Program (CFDA 16.838). This 3-year Project Grant award will enable the county to expand and enhance comprehensive programs to identify, respond to, treat, and support those impacted by the overdose crisis and the impacts of opioid, stimulant, or other substance use in the Stanislaus County...

The Bureau of Justice Assistance (BJA) awarded a $1,300,000 Comprehensive Opioid, Stimulant, and Substance Use Program (COSSUP) grant to the City of Long Beach, California. The grant will fund the expansion of the city's Law Enforcement Assisted Diversion (LEAD) model by creating a Field-Based Care Coordination Team (CCT) to increase participant enrollment, connect participants to treatment, and reduce recidivism. Key components of the project include establishing a partnership with the Los...

This $663,040 Formula Grant award from the U.S. Department of Justice's Bureau of Justice Assistance (CFDA 16.593 - Residential Substance Abuse Treatment for State Prisoners Program) will support the Indiana Criminal Justice Institute (ICJI) in developing and implementing substance use disorder (SUD) treatment programs within state, local, and tribal correctional facilities in Indiana. The grant will enable ICJI to provide evidence-based residential treatment, counseling, and reentry services to...

This $425,352 federal Formula Grant award from the Bureau of Justice Assistance (CFDA 16.593 - Residential Substance Abuse Treatment for State Prisoners Program) supports the Washington State Health Care Authority's (HCA) efforts to provide evidence-based substance use disorder (SUD) treatment and aftercare services for incarcerated individuals at four correctional facilities in Washington state. The project aims to create therapeutic environments and deliver a range of evidence-based,...